Clinical

This channel newsfeed includes clinical content on treating patients or the clinical implications in a variety of cardiac subspecialties and disease states. The channel includes news on cardiac surgery, interventional cardiologyheart failure, electrophysiologyhypertension, structural heart disease, use of pharmaceuticals, and COVID-19.   

Thumbnail

Restenosis more common after carotid stenting, linked to stroke risk

Restenosis of the carotid arteries is more likely after stenting than endarterectomy and increases the likelihood of stroke, according to a subanalysis of a randomized trial published in The Lancet Neurology.

Thumbnail

Green tea component may prevent heart attack, stroke

A compound found in green tea can break up the plaque that causes atherosclerosis, according to research published May 31 in the Journal of Biological Chemistry.

Thumbnail

Fast walking speed associated with reduced mortality risk

Putting some extra pep in your step may prolong your life, according to a study published June 1 in the British Journal of Sports Medicine.

Virtual hypertension visits offer convenience for clinicians, without compromising care

Virtual primary care visits for hypertension follow-ups are just as effective as in-person visits to maintain blood pressure control, according to a new study published on May 23 in the Journal of General Internal Medicine.

Thumbnail

Class I recall issued for Medtronic’s HeartWare VAD

The electrical connection between the ventricular assist device (VAD)'s power source and its controller may be interrupted due to oxidation on the connecting surfaces, according to the agency’s recall notice.

Thumbnail

St. Luke’s in Houston suspends heart transplant program after patient deaths

Baylor St. Luke’s Medical Center in Houston has temporarily suspended its heart transplant program, two weeks after a joint investigation by the Houston Chronicle and ProPublica detailed its poor performance.

SGLT-2 inhibitors cut heart failure risk for diabetics with, without CVD

Type 2 diabetics who take sodium-glucose co-transporter-2 (SGLT-2) inhibitors experience similar relative reductions in heart failure and mortality regardless of whether they have cardiovascular disease (CVD), according to a subanalysis of the CVD-REAL study published in the Journal of the American College of Cardiology.

Thumbnail

Image-guided atherectomy system gains FDA approval

Avinger announced last week the FDA has approved its next-generation Pantheris Lumivascular atherectomy device, which is used to remove plaque from a blood vessel in those with peripheral artery disease (PAD).